GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioceltix SA (WAR:BCX) » Definitions » Other Net Income (Loss)

Bioceltix (WAR:BCX) Other Net Income (Loss) : zł0.00 Mil (TTM As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Bioceltix Other Net Income (Loss)?

Bioceltix's Other Net Income (Loss) for the three months ended in Sep. 2024 was zł-0.00 Mil. Its Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 was zł0.00 Mil.

Bioceltix's quarterly Other Net Income (Loss) declined from Mar. 2024 (zł0.00 Mil) to Jun. 2024 (zł-0.00 Mil) but then increased from Jun. 2024 (zł-0.00 Mil) to Sep. 2024 (zł-0.00 Mil).

Bioceltix's annual Other Net Income (Loss) increased from Dec. 2021 (zł0.00 Mil) to Dec. 2022 (zł0.00 Mil) but then declined from Dec. 2022 (zł0.00 Mil) to Dec. 2023 (zł-0.00 Mil).

Bioceltix Other Net Income (Loss) Historical Data

The historical data trend for Bioceltix's Other Net Income (Loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bioceltix Other Net Income (Loss) Chart

Bioceltix Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Other Net Income (Loss)
- - - - -

Bioceltix Quarterly Data
Dec19 Jun20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Other Net Income (Loss) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bioceltix Other Net Income (Loss) Calculation

Different companies can and do choose to report each of income statement items separately. Yet, there are a variety of items which are simply too numerous to list. Therefore GuruFocus uses a standardized financial statement format for all companies. Other Net Income (Loss) may include but is not limited to items such as net income (loss) from discontinuing operations, extraordinary, earnings from equity interest net of tax, etc. After-tax income and Other Net Income (Loss) together constitute Net Income Including Noncontrolling Interests.

Other Net Income (Loss) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was zł0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bioceltix Other Net Income (Loss) Related Terms

Thank you for viewing the detailed overview of Bioceltix's Other Net Income (Loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Bioceltix Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bioceltix SA (WAR:BCX) » Definitions » Other Net Income (Loss)
Comparable Companies
WAR:PTG WAR:MAB WAR:MOC WAR:BIO WAR:SVE WAR:URT WAR:CTX WAR:PHR WAR:RDG WAR:PUR OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA XBRU:ARGX HKSE:02269 BNTX
Traded in Other Exchanges
N/A
Address
Bierutowska 57-59 Street, Wroclaw, POL, 51-317
Website
https://www.bioceltix.com
Bioceltix SA develops therapies for veterinary use that harness the immunomodulatory properties of mesenchymal stem cells. Its pipeline products include BCX-CM-J for Degenerative joint lesions; BCX-CM-S for Autoimmune and inflammatory diseases in dogs; BCX-EM for Tendon damage and BCX-FM for Gingivostomatitis.